Nifedipine-induced gingival hypertrophy.

نویسندگان

  • Masami Matsumura
  • Yasunori Suzuki
  • Masakazu Yamagishi
  • Mitsuhiro Kawano
چکیده

A 55-year-old man was referred to us because of renal dysfunction (serum creatinine 1.82 mg/dL). Three years earlier, he had aortic dissection associated with left renal artery occlusion and had undergone surgery for ascending aorta and aortic arch replacement. He had been receiving the following medications for 3 years; nifedipine (Adalat-CR) 40 mg, carvedilol 10 mg, aspirin 100 mg, allopurinol 200 mg, and famotidine 10 mg daily. Examination revealed severe gingival hypertrophy with bleeding (Picture 1). These manifestations prevented him from tooth brushing. We substituted losartan potassium 25 mg daily for nifedipine. Gingival hypertrophy improved 4 months later (Picture 2) and it was resolved 3 years after nifedipine withdrawal (Picture 3). Calcium channel blockers, phenytoin, and cyclosporin are known to cause gingival hypertrophy. The mechanisms are still unclear. Cessation of the drug or meticulous plaque control is recommended for treatment (1). We should not overlook this adverse event which can cause an unpleasant odor, bleeding, infections, or eating difficulty (1).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Nonsurgical Management of Nifedipine Induced Gingival Overgrowth

Drug-induced gingival overgrowth is frequently associated with three particular drugs: phenytoin, cyclosporin, and nifedipine. As gingival enlargement develops, it affects the normal oral hygiene practice and may interfere with masticatory functions. The awareness in the medical community about this possible side effect of nifedipine is less when compared to the effects of phenytoin and cyclosp...

متن کامل

Changes in Inflammatory Markers in Bacterial- and Nifedipine-Induced Gingival Inflammation

BACKGROUND Inflammatory gingival enlargement is a common observation in routine dental practice. Drugs like nifedipine, used for hypertension and Porphyromonas gingivalis infection-induced gingival enlargement is of a major concern. The current study aims to identify the inflammatory response of the gingival enlargement by measuring the major inflammatory markers fibrinogen and C-reactive prote...

متن کامل

A Rare Case Report of Amlodipine-Induced Gingival Enlargement and Review of Its Pathogenesis

Gingival enlargement is a common clinical feature of gingival and periodontal diseases. It is an unwanted side effect of certain systemic drugs given for nondental treatment. It is being reported with three main groups of drugs like calcium channel blockers (CCBs), immunosuppressants, and anticonvulsants. Among calcium channel blockers, nifedipine causes gingival hyperplasia in about 10% of pat...

متن کامل

Drug Induced Gingival Enlargement

Gingival enlargement is an abnormal growth of the periodontal tissue. Several causes of gingival enlargement are known, and the most recognized is drug-induced (iatrogenic) gingival enlargement (GE) . Antiepileptic (Phenytoin PNT), Immunosuppressant (Cyclosporin A), Calcium channel blockers ( Nifedipine) are implicated. GE is the most common ADR in the young adults and children receiving PNT as...

متن کامل

Therapy for nifedipine-induced gingival overgrowth by saireito in rats

OBJECTIVE A calcium antagonist, nifedipine, causes gingival overgrowth as a side effect. It has been confirmed that the Japanese traditional medicine, Saireito, inhibits the nifedipine-induced proliferation of gingival fibroblasts in vitro. We performed an in vivo experiment to determine whether Saireito has a therapeutic use in the treatment of nifedipine-induced gingival overgrowth. METHODS...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Internal medicine

دوره 51 1  شماره 

صفحات  -

تاریخ انتشار 2012